Summary: Bacteroides species are significant clinical pathogens and are found in most
anaerobic infections, with an associated mortality of more than 19%. The bacteria maintain a …

Metronidazole has been used for the treatment of infections for> 45 years and is still
successfully used for the treatment of trichomoniasis, amoebiasis, and giardiasis. Anaerobic …

Evidence-based guidelines for managing patients with intra-abdominal infection were
prepared by an Expert Panel of the Surgical Infection Society and the Infectious Diseases …

Anaerobic bacteria have pivotal roles in the microbiota of humans and they are significant
infectious agents involved in many pathological processes, both in immunocompetent and …

Rapid and reliable detection and identification of bacterial species are necessary for
diagnosis and efficient treatment. Until recently, bacterial identification in clinical laboratories …

Antimicrobial susceptibility testing (AST) is indicated for pathogens contributing to an
infectious process that warrants antimicrobial therapy if susceptibility to antimicrobials …

The susceptibilities of 824 Bacteroides fragilis group isolates against nine antibiotics were
evaluated in a Europe-wide study involving 13 countries. Species determination, by different …

Antimicrobial chemotherapy has played a vital role in the treatment of human infectious
diseases since the discovery of penicillin in the 1920s. Hundreds of antimicrobial agents …

Recent outbreaks of Clostridium difficile infection (CDI) in North America have been due to a
more virulent, possibly more resistant strain that causes more-severe disease, making …

Complicated intra-abdominal infections are an important cause of morbidity and are
frequently associated with poor prognosis, particularly in higher risk patients. Well defined …